Oak Fine Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 2662.49%
(FY 2023)
- Ebitda 100555.90%
(FY 2023)
- Net Worth 173.39%
(FY 2023)
- Total Assets 616.41%
(FY 2023)
About Oak Fine Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajender Chandak and Niraj Chandak serve as directors at the Company.
- CIN/LLPIN
U24299TG2021PTC149044
- Company No.
149044
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 2021
- Date of AGM
03 Oct 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Oak Fine Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajender Chandak  | Director | 26-Feb-2021 | Current |
| Niraj Chandak | Director | 26-Feb-2021 | Current |
Financial Performance and Corporate Structure Insights of Oak Fine Chemicals.
Oak Fine Chemicals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 2662.49% increase in profit. The company's net worth Soared by an impressive increase of 173.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oak Fine Chemicals?
Unlock access to Oak Fine Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Enco Speciality Chemicals Private LimitedActive 2 years 11 months
Rajender Chandak and Niraj Chandak are mutual person
- Bharath Advanced Therapeutics Private LimitedActive 11 months 1 day
Rajender Chandak is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oak Fine Chemicals?
Oak Fine Chemicals has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oak Fine Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oak Fine Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
